Related references
Note: Only part of the references are listed.Pseudo-outbreak of Mycobacterium paragordonae in a hospital: possible role of the aerator/rectifier connected to the faucet of the water supply system
I Takajo et al.
JOURNAL OF HOSPITAL INFECTION (2020)
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
Susan L. Baldwin et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Editorial: Amoebae as Host Models to Study the Interaction With Pathogens
Sascha Thewes et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Insights From the Genome Sequence of Mycobacterium paragordonae, a Potential Novel Live Vaccine for Preventing Mycobacterial Infections: The Putative Role of Type VII Secretion Systems for an Intracellular Lifestyle Within Free-Living Environmental Predators
Byoung-Jun Kim et al.
FRONTIERS IN MICROBIOLOGY (2019)
NTM drug discovery: status, gaps and the way forward
Mu-Lu Wu et al.
DRUG DISCOVERY TODAY (2018)
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
Laurent R. Chiarelli et al.
SCIENTIFIC REPORTS (2018)
Challenges of NTM Drug Development
Joseph O. Falkinham
FRONTIERS IN MICROBIOLOGY (2018)
Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
Valentin Trofimov et al.
SCIENTIFIC REPORTS (2018)
Identification of nontuberculous mycobacteria isolated from hospital water by sequence analysis of the hsp65 and 16S rRNA genes
Mehdi Roshdi Maleki et al.
JOURNAL OF WATER AND HEALTH (2017)
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors
Marta Esposito et al.
ACS INFECTIOUS DISEASES (2017)
Screening, isolation and molecular identification of biodegrading mycobacteria from Iranian ecosystems and analysis of their biodegradation activity
Davood Azadi et al.
AMB EXPRESS (2017)
A temperature sensitive Mycobacterium paragordonae induces enhanced protective immune responses against mycobacterial infections in the mouse model
Byoung-Jun Kim et al.
SCIENTIFIC REPORTS (2017)
Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus
Tae Sung Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria
Isha Soni et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2016)
Species diversity and molecular characterization of nontuberculous mycobacteria in hospital water system of a developing country, Iran
Davood Azadi et al.
MICROBIAL PATHOGENESIS (2016)
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Christian Dupont et al.
MOLECULAR MICROBIOLOGY (2016)
Evaluation of the SLOMYCO Sensititre® panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates
Marion Chazel et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
Khisimuzi Mdluli et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Characterization of 17 strains belonging to the Mycobacterium simiae complex and description of Mycobacterium paraense sp nov.
Ana R. Fusco da Costa et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2015)
Take five - Type VII secretion systems of Mycobacteria
Edith N. G. Houben et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Tuberculosis drug discovery in the post-post-genomic era
Benoit Lechartier et al.
EMBO MOLECULAR MEDICINE (2014)
Mycobacterium paragordonae sp nov., a slowly growing, scotochromogenic species closely related to Mycobacterium gordonae
Byoung-Jun Kim et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2014)
Amoebae as a tool to isolate new bacterial species, to discover new virulence factors and to study the host-pathogen interactions
Nicolo Tosetti et al.
MICROBIAL PATHOGENESIS (2014)
Establishment and Validation of Whole-Cell Based Fluorescence Assays to Identify Anti-Mycobacterial Compounds Using the Acanthamoeba castellanii - Mycobacterium marinum Host-Pathogen System
Sebastien Kicka et al.
PLOS ONE (2014)
Future target-based drug discovery for tuberculosis?
Bavesh Davandra Kana et al.
TUBERCULOSIS (2014)
Whole-Cell Screening-Based Identification of Inhibitors against the Intraphagosomal Survival of Mycobacterium tuberculosis
Garima Khare et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
Lluis Ballell et al.
CHEMMEDCHEM (2013)
Increased Incidence of Cutaneous Nontuberculous Mycobacterial Infection, 1980 to 2009: A Population-Based Study
Ashley B. Wentworth et al.
MAYO CLINIC PROCEEDINGS (2013)
A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
Juliane Ollinger et al.
PLOS ONE (2013)
Exploring Anti-Bacterial Compounds against Intracellular Legionella
Christopher F. Harrison et al.
PLOS ONE (2013)
Virulence factors of the Mycobacterium tuberculosis complex
Marina A. Forrellad et al.
VIRULENCE (2013)
Conserved Mechanisms of Mycobacterium marinum Pathogenesis within the Environmental Amoeba Acanthamoeba castellanii
George M. Kennedy et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2012)
Challenges of Antibacterial Discovery
Lynn L. Silver
CLINICAL MICROBIOLOGY REVIEWS (2011)
A Sensitive High-Throughput Assay for Evaluating Host-Pathogen Interactions in Cryptococcus neoformans Infection
Deepa Srikanta et al.
PLOS ONE (2011)
Pathogen-host interactions in Dictyostelium, Legionella, Mycobacterium and other pathogens
Michael Steinert
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?
Michael U. Shiloh et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Optimisation of Bioluminescent Reporters for Use with Mycobacteria
Nuria Andreu et al.
PLOS ONE (2010)
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
Kevin Pethe et al.
NATURE COMMUNICATIONS (2010)
Unfinished business: target-based drug discovery
David Brown
DRUG DISCOVERY TODAY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Antibiotic treatment in vitro of phenotypically tolerant bacterial populations
Camilla Wiuff et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
New models for the study of Mycobacterium-host interactions
TC Pozos et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Intracellular replication of Mycobacterium marinum within Dictyostelium discoideum:: Efficient replication in the absence of host coronin
JM Solomon et al.
INFECTION AND IMMUNITY (2003)
Various bacterial pathogens and symbionts infect the amoeba Dictyostelium discoideum
C Skriwan et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2002)
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
A Somoskovi et al.
RESPIRATORY RESEARCH (2001)
Share Paper
